Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer

Mark D. Pegram, Tadeusz Pienkowski, Donald W. Northfelt, Wolfgang Eiermann, Ravi Patel, Pierre Fumoleau, Eleonor Quan, John Crown, Deborah Toppmeyer, Michael Smylie, Alessandro Riva, Sandra Blitz, Michael F. Press, David Reese, Mary Ann Lindsay, Dennis J. Slamon

Research output: Contribution to journalArticlepeer-review

254 Scopus citations

Fingerprint Dive into the research topics of 'Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences